Matches in Wikidata for { <http://www.wikidata.org/entity/Q64606708> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q64606708 description "clinical trial" @default.
- Q64606708 description "ensayu clínicu" @default.
- Q64606708 description "klinisch onderzoek" @default.
- Q64606708 description "клінічне випробування" @default.
- Q64606708 description "կլինիկական փորձարկում" @default.
- Q64606708 name "Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus" @default.
- Q64606708 type Item @default.
- Q64606708 label "Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus" @default.
- Q64606708 prefLabel "Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus" @default.
- Q64606708 P1050 Q64606708-150F973E-7D54-4EDD-8478-653FAA426C8F @default.
- Q64606708 P1132 Q64606708-9AC53FEC-CD9F-42F7-8650-BC1600D5DA7F @default.
- Q64606708 P1476 Q64606708-D4EECDE3-5DA4-45B5-AD19-A39B28E289B1 @default.
- Q64606708 P17 Q64606708-6AA00FBE-7079-4603-93EB-523A1358237B @default.
- Q64606708 P17 Q64606708-6B2D8F09-2A03-45B1-AEE4-90F24DC0C78E @default.
- Q64606708 P17 Q64606708-9BF91FF8-63DF-4888-A2FD-B43EB9C13A6B @default.
- Q64606708 P17 Q64606708-ADA58C7E-CAB7-4DC8-9356-FF20A64792A9 @default.
- Q64606708 P17 Q64606708-BE74C9A9-073B-4A0A-BCE5-2D9155D428F1 @default.
- Q64606708 P17 Q64606708-F28D2F16-57B5-4C00-9F85-BCDDD1CE8487 @default.
- Q64606708 P2899 Q64606708-FB014D81-B81E-4814-A366-AB7DAF98FCE4 @default.
- Q64606708 P3098 Q64606708-BFB5351B-9506-4440-A905-6AF8199980E4 @default.
- Q64606708 P31 Q64606708-DDCF6902-BD67-404B-9354-7E43EF5D6887 @default.
- Q64606708 P4135 Q64606708-821ABCD4-674D-421E-9E7C-9B868B6587F2 @default.
- Q64606708 P4844 Q64606708-63A52571-AB98-457D-BC5F-46688884B619 @default.
- Q64606708 P4844 Q64606708-F928E0F9-68B1-4904-8DBB-AC10A311EFF7 @default.
- Q64606708 P580 Q64606708-AE4282C7-BCD6-41CA-B032-53E9BD8F12B1 @default.
- Q64606708 P582 Q64606708-9BDE2D40-AC0F-45ED-AFD5-DA59F08BD191 @default.
- Q64606708 P6099 Q64606708-A1A452AA-8A20-4822-B26A-E2A19A011EC5 @default.
- Q64606708 P8363 Q64606708-74361E48-346B-4A1D-9F8A-A46BA2AB7702 @default.
- Q64606708 P1050 Q12206 @default.
- Q64606708 P1132 "+464" @default.
- Q64606708 P1476 "A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Once Weekly Exenatide Therapy Added to Titrated Basal Insulin Glargine Compared to Placebo Added to Titrated Basal Insulin Glargine in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Basal Insulin Glargine With or Without Metformin" @default.
- Q64606708 P17 Q214 @default.
- Q64606708 P17 Q218 @default.
- Q64606708 P17 Q258 @default.
- Q64606708 P17 Q28 @default.
- Q64606708 P17 Q30 @default.
- Q64606708 P17 Q36 @default.
- Q64606708 P2899 "+18" @default.
- Q64606708 P3098 "NCT02229383" @default.
- Q64606708 P31 Q30612 @default.
- Q64606708 P4135 "+130" @default.
- Q64606708 P4844 Q19484 @default.
- Q64606708 P4844 Q417762 @default.
- Q64606708 P580 "2014-09-06T00:00:00Z" @default.
- Q64606708 P582 "2016-08-29T00:00:00Z" @default.
- Q64606708 P6099 Q42824827 @default.
- Q64606708 P8363 Q78089383 @default.